nodes	percent_of_prediction	percent_of_DWPC	metapath
Dolasetron—CYP2C9—Medroxyprogesterone Acetate—uterine cancer	0.184	0.27	CbGbCtD
Dolasetron—CYP2C9—Progesterone—uterine cancer	0.122	0.179	CbGbCtD
Dolasetron—CYP2D6—Progesterone—uterine cancer	0.111	0.163	CbGbCtD
Dolasetron—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.107	0.157	CbGbCtD
Dolasetron—CYP3A4—Progesterone—uterine cancer	0.0707	0.104	CbGbCtD
Dolasetron—CYP2D6—Doxorubicin—uterine cancer	0.0339	0.0498	CbGbCtD
Dolasetron—CYP3A4—Etoposide—uterine cancer	0.0316	0.0465	CbGbCtD
Dolasetron—CYP3A4—Doxorubicin—uterine cancer	0.0216	0.0317	CbGbCtD
Dolasetron—Hiccups—Doxorubicin—uterine cancer	0.000656	0.00206	CcSEcCtD
Dolasetron—Ventricular tachycardia—Doxorubicin—uterine cancer	0.000656	0.00206	CcSEcCtD
Dolasetron—Gastrointestinal pain—Medroxyprogesterone Acetate—uterine cancer	0.000653	0.00205	CcSEcCtD
Dolasetron—Myalgia—Dactinomycin—uterine cancer	0.00065	0.00204	CcSEcCtD
Dolasetron—Hypersensitivity—Progesterone—uterine cancer	0.00065	0.00204	CcSEcCtD
Dolasetron—Eructation—Doxorubicin—uterine cancer	0.000644	0.00202	CcSEcCtD
Dolasetron—Discomfort—Dactinomycin—uterine cancer	0.000642	0.00201	CcSEcCtD
Dolasetron—Influenza like illness—Doxorubicin—uterine cancer	0.000637	0.002	CcSEcCtD
Dolasetron—Urticaria—Medroxyprogesterone Acetate—uterine cancer	0.000635	0.00199	CcSEcCtD
Dolasetron—Asthenia—Progesterone—uterine cancer	0.000633	0.00198	CcSEcCtD
Dolasetron—Abdominal pain—Medroxyprogesterone Acetate—uterine cancer	0.000632	0.00198	CcSEcCtD
Dolasetron—Body temperature increased—Medroxyprogesterone Acetate—uterine cancer	0.000632	0.00198	CcSEcCtD
Dolasetron—Pruritus—Progesterone—uterine cancer	0.000624	0.00196	CcSEcCtD
Dolasetron—Oedema—Dactinomycin—uterine cancer	0.000623	0.00195	CcSEcCtD
Dolasetron—Abnormal vision—Epirubicin—uterine cancer	0.000618	0.00194	CcSEcCtD
Dolasetron—Aplastic anaemia—Doxorubicin—uterine cancer	0.000616	0.00193	CcSEcCtD
Dolasetron—Sepsis—Epirubicin—uterine cancer	0.000615	0.00193	CcSEcCtD
Dolasetron—Thrombocytopenia—Dactinomycin—uterine cancer	0.00061	0.00191	CcSEcCtD
Dolasetron—Diarrhoea—Progesterone—uterine cancer	0.000603	0.00189	CcSEcCtD
Dolasetron—Phlebitis—Epirubicin—uterine cancer	0.000597	0.00187	CcSEcCtD
Dolasetron—Thrombophlebitis—Epirubicin—uterine cancer	0.000594	0.00186	CcSEcCtD
Dolasetron—Anorexia—Dactinomycin—uterine cancer	0.000594	0.00186	CcSEcCtD
Dolasetron—Blood alkaline phosphatase increased—Epirubicin—uterine cancer	0.000591	0.00185	CcSEcCtD
Dolasetron—Flushing—Etoposide—uterine cancer	0.000589	0.00185	CcSEcCtD
Dolasetron—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.000589	0.00185	CcSEcCtD
Dolasetron—Hepatic function abnormal—Epirubicin—uterine cancer	0.000589	0.00185	CcSEcCtD
Dolasetron—Dizziness—Progesterone—uterine cancer	0.000583	0.00183	CcSEcCtD
Dolasetron—Vascular purpura—Epirubicin—uterine cancer	0.000575	0.0018	CcSEcCtD
Dolasetron—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.000573	0.0018	CcSEcCtD
Dolasetron—Abnormal vision—Doxorubicin—uterine cancer	0.000572	0.00179	CcSEcCtD
Dolasetron—Chills—Etoposide—uterine cancer	0.00057	0.00179	CcSEcCtD
Dolasetron—Sepsis—Doxorubicin—uterine cancer	0.000569	0.00178	CcSEcCtD
Dolasetron—Musculoskeletal discomfort—Dactinomycin—uterine cancer	0.000568	0.00178	CcSEcCtD
Dolasetron—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.000565	0.00177	CcSEcCtD
Dolasetron—Renal failure acute—Epirubicin—uterine cancer	0.000557	0.00175	CcSEcCtD
Dolasetron—Rash—Progesterone—uterine cancer	0.000556	0.00174	CcSEcCtD
Dolasetron—Dermatitis—Progesterone—uterine cancer	0.000555	0.00174	CcSEcCtD
Dolasetron—Phlebitis—Doxorubicin—uterine cancer	0.000553	0.00173	CcSEcCtD
Dolasetron—Headache—Progesterone—uterine cancer	0.000552	0.00173	CcSEcCtD
Dolasetron—Thrombophlebitis—Doxorubicin—uterine cancer	0.00055	0.00172	CcSEcCtD
Dolasetron—Increased appetite—Epirubicin—uterine cancer	0.000548	0.00172	CcSEcCtD
Dolasetron—Blood alkaline phosphatase increased—Doxorubicin—uterine cancer	0.000547	0.00172	CcSEcCtD
Dolasetron—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.000547	0.00171	CcSEcCtD
Dolasetron—Hepatic function abnormal—Doxorubicin—uterine cancer	0.000545	0.00171	CcSEcCtD
Dolasetron—Decreased appetite—Dactinomycin—uterine cancer	0.000542	0.0017	CcSEcCtD
Dolasetron—Dysgeusia—Etoposide—uterine cancer	0.000541	0.0017	CcSEcCtD
Dolasetron—Fatigue—Dactinomycin—uterine cancer	0.000537	0.00168	CcSEcCtD
Dolasetron—Purpura—Epirubicin—uterine cancer	0.000534	0.00167	CcSEcCtD
Dolasetron—Pain—Dactinomycin—uterine cancer	0.000533	0.00167	CcSEcCtD
Dolasetron—Vascular purpura—Doxorubicin—uterine cancer	0.000532	0.00167	CcSEcCtD
Dolasetron—Anaphylactoid reaction—Epirubicin—uterine cancer	0.000532	0.00167	CcSEcCtD
Dolasetron—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.000528	0.00166	CcSEcCtD
Dolasetron—Renal failure acute—Doxorubicin—uterine cancer	0.000516	0.00162	CcSEcCtD
Dolasetron—Feeling abnormal—Dactinomycin—uterine cancer	0.000514	0.00161	CcSEcCtD
Dolasetron—Ill-defined disorder—Etoposide—uterine cancer	0.000513	0.00161	CcSEcCtD
Dolasetron—Anaemia—Etoposide—uterine cancer	0.000511	0.0016	CcSEcCtD
Dolasetron—Gastrointestinal pain—Dactinomycin—uterine cancer	0.00051	0.0016	CcSEcCtD
Dolasetron—Increased appetite—Doxorubicin—uterine cancer	0.000507	0.00159	CcSEcCtD
Dolasetron—Rash—Medroxyprogesterone Acetate—uterine cancer	0.000504	0.00158	CcSEcCtD
Dolasetron—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.000503	0.00158	CcSEcCtD
Dolasetron—Headache—Medroxyprogesterone Acetate—uterine cancer	0.000501	0.00157	CcSEcCtD
Dolasetron—Malaise—Etoposide—uterine cancer	0.000498	0.00156	CcSEcCtD
Dolasetron—Face oedema—Epirubicin—uterine cancer	0.000497	0.00156	CcSEcCtD
Dolasetron—Vertigo—Etoposide—uterine cancer	0.000497	0.00156	CcSEcCtD
Dolasetron—Purpura—Doxorubicin—uterine cancer	0.000494	0.00155	CcSEcCtD
Dolasetron—Abdominal pain—Dactinomycin—uterine cancer	0.000493	0.00154	CcSEcCtD
Dolasetron—Body temperature increased—Dactinomycin—uterine cancer	0.000493	0.00154	CcSEcCtD
Dolasetron—Anaphylactoid reaction—Doxorubicin—uterine cancer	0.000492	0.00154	CcSEcCtD
Dolasetron—Cardiac arrest—Epirubicin—uterine cancer	0.000489	0.00153	CcSEcCtD
Dolasetron—Loss of consciousness—Etoposide—uterine cancer	0.000486	0.00152	CcSEcCtD
Dolasetron—Ataxia—Epirubicin—uterine cancer	0.000484	0.00152	CcSEcCtD
Dolasetron—Cough—Etoposide—uterine cancer	0.000482	0.00151	CcSEcCtD
Dolasetron—Convulsion—Etoposide—uterine cancer	0.000479	0.0015	CcSEcCtD
Dolasetron—Dehydration—Epirubicin—uterine cancer	0.000478	0.0015	CcSEcCtD
Dolasetron—Hypertension—Etoposide—uterine cancer	0.000477	0.0015	CcSEcCtD
Dolasetron—Chest pain—Etoposide—uterine cancer	0.000471	0.00148	CcSEcCtD
Dolasetron—Orthostatic hypotension—Epirubicin—uterine cancer	0.00047	0.00147	CcSEcCtD
Dolasetron—Discomfort—Etoposide—uterine cancer	0.000465	0.00146	CcSEcCtD
Dolasetron—Aspartate aminotransferase increased—Epirubicin—uterine cancer	0.000463	0.00145	CcSEcCtD
Dolasetron—Face oedema—Doxorubicin—uterine cancer	0.00046	0.00144	CcSEcCtD
Dolasetron—Hypersensitivity—Dactinomycin—uterine cancer	0.000459	0.00144	CcSEcCtD
Dolasetron—Confusional state—Etoposide—uterine cancer	0.000455	0.00143	CcSEcCtD
Dolasetron—Alanine aminotransferase increased—Epirubicin—uterine cancer	0.000454	0.00142	CcSEcCtD
Dolasetron—Cardiac arrest—Doxorubicin—uterine cancer	0.000453	0.00142	CcSEcCtD
Dolasetron—Anaphylactic shock—Etoposide—uterine cancer	0.000451	0.00141	CcSEcCtD
Dolasetron—Abdominal distension—Epirubicin—uterine cancer	0.000448	0.0014	CcSEcCtD
Dolasetron—Ataxia—Doxorubicin—uterine cancer	0.000448	0.0014	CcSEcCtD
Dolasetron—Asthenia—Dactinomycin—uterine cancer	0.000447	0.0014	CcSEcCtD
Dolasetron—Dehydration—Doxorubicin—uterine cancer	0.000443	0.00139	CcSEcCtD
Dolasetron—Thrombocytopenia—Etoposide—uterine cancer	0.000442	0.00138	CcSEcCtD
Dolasetron—Tachycardia—Etoposide—uterine cancer	0.00044	0.00138	CcSEcCtD
Dolasetron—Hyperhidrosis—Etoposide—uterine cancer	0.000436	0.00137	CcSEcCtD
Dolasetron—Pancreatitis—Epirubicin—uterine cancer	0.000436	0.00137	CcSEcCtD
Dolasetron—Orthostatic hypotension—Doxorubicin—uterine cancer	0.000435	0.00136	CcSEcCtD
Dolasetron—Anorexia—Etoposide—uterine cancer	0.00043	0.00135	CcSEcCtD
Dolasetron—Aspartate aminotransferase increased—Doxorubicin—uterine cancer	0.000429	0.00134	CcSEcCtD
Dolasetron—Diarrhoea—Dactinomycin—uterine cancer	0.000426	0.00134	CcSEcCtD
Dolasetron—Hypotension—Etoposide—uterine cancer	0.000422	0.00132	CcSEcCtD
Dolasetron—Alanine aminotransferase increased—Doxorubicin—uterine cancer	0.00042	0.00132	CcSEcCtD
Dolasetron—Dysuria—Epirubicin—uterine cancer	0.000416	0.0013	CcSEcCtD
Dolasetron—Abdominal distension—Doxorubicin—uterine cancer	0.000414	0.0013	CcSEcCtD
Dolasetron—Paraesthesia—Etoposide—uterine cancer	0.000405	0.00127	CcSEcCtD
Dolasetron—Pancreatitis—Doxorubicin—uterine cancer	0.000403	0.00126	CcSEcCtD
Dolasetron—Dyspnoea—Etoposide—uterine cancer	0.000402	0.00126	CcSEcCtD
Dolasetron—Somnolence—Etoposide—uterine cancer	0.000401	0.00126	CcSEcCtD
Dolasetron—Pneumonia—Epirubicin—uterine cancer	0.000399	0.00125	CcSEcCtD
Dolasetron—Drowsiness—Epirubicin—uterine cancer	0.000396	0.00124	CcSEcCtD
Dolasetron—Rash—Dactinomycin—uterine cancer	0.000393	0.00123	CcSEcCtD
Dolasetron—Decreased appetite—Etoposide—uterine cancer	0.000392	0.00123	CcSEcCtD
Dolasetron—Fatigue—Etoposide—uterine cancer	0.000389	0.00122	CcSEcCtD
Dolasetron—Stomatitis—Epirubicin—uterine cancer	0.000386	0.00121	CcSEcCtD
Dolasetron—Jaundice—Epirubicin—uterine cancer	0.000386	0.00121	CcSEcCtD
Dolasetron—Pain—Etoposide—uterine cancer	0.000386	0.00121	CcSEcCtD
Dolasetron—Constipation—Etoposide—uterine cancer	0.000386	0.00121	CcSEcCtD
Dolasetron—Dysuria—Doxorubicin—uterine cancer	0.000385	0.00121	CcSEcCtD
Dolasetron—Haematuria—Epirubicin—uterine cancer	0.000378	0.00119	CcSEcCtD
Dolasetron—Epistaxis—Epirubicin—uterine cancer	0.000374	0.00117	CcSEcCtD
Dolasetron—Feeling abnormal—Etoposide—uterine cancer	0.000372	0.00117	CcSEcCtD
Dolasetron—Pneumonia—Doxorubicin—uterine cancer	0.000369	0.00116	CcSEcCtD
Dolasetron—Gastrointestinal pain—Etoposide—uterine cancer	0.000369	0.00116	CcSEcCtD
Dolasetron—Drowsiness—Doxorubicin—uterine cancer	0.000367	0.00115	CcSEcCtD
Dolasetron—Bradycardia—Epirubicin—uterine cancer	0.000362	0.00114	CcSEcCtD
Dolasetron—Urticaria—Etoposide—uterine cancer	0.000358	0.00112	CcSEcCtD
Dolasetron—Jaundice—Doxorubicin—uterine cancer	0.000358	0.00112	CcSEcCtD
Dolasetron—Stomatitis—Doxorubicin—uterine cancer	0.000358	0.00112	CcSEcCtD
Dolasetron—Body temperature increased—Etoposide—uterine cancer	0.000357	0.00112	CcSEcCtD
Dolasetron—Abdominal pain—Etoposide—uterine cancer	0.000357	0.00112	CcSEcCtD
Dolasetron—Oedema peripheral—Epirubicin—uterine cancer	0.000351	0.0011	CcSEcCtD
Dolasetron—Haematuria—Doxorubicin—uterine cancer	0.00035	0.0011	CcSEcCtD
Dolasetron—Epistaxis—Doxorubicin—uterine cancer	0.000346	0.00108	CcSEcCtD
Dolasetron—Visual impairment—Epirubicin—uterine cancer	0.000343	0.00108	CcSEcCtD
Dolasetron—Bradycardia—Doxorubicin—uterine cancer	0.000335	0.00105	CcSEcCtD
Dolasetron—Hypersensitivity—Etoposide—uterine cancer	0.000332	0.00104	CcSEcCtD
Dolasetron—Tinnitus—Epirubicin—uterine cancer	0.000332	0.00104	CcSEcCtD
Dolasetron—Flushing—Epirubicin—uterine cancer	0.00033	0.00104	CcSEcCtD
Dolasetron—Oedema peripheral—Doxorubicin—uterine cancer	0.000324	0.00102	CcSEcCtD
Dolasetron—Asthenia—Etoposide—uterine cancer	0.000324	0.00101	CcSEcCtD
Dolasetron—Chills—Epirubicin—uterine cancer	0.000319	0.001	CcSEcCtD
Dolasetron—Pruritus—Etoposide—uterine cancer	0.000319	0.001	CcSEcCtD
Dolasetron—Arrhythmia—Epirubicin—uterine cancer	0.000318	0.000997	CcSEcCtD
Dolasetron—Visual impairment—Doxorubicin—uterine cancer	0.000317	0.000995	CcSEcCtD
Dolasetron—Diarrhoea—Etoposide—uterine cancer	0.000309	0.000968	CcSEcCtD
Dolasetron—Tinnitus—Doxorubicin—uterine cancer	0.000307	0.000963	CcSEcCtD
Dolasetron—Flushing—Doxorubicin—uterine cancer	0.000306	0.000958	CcSEcCtD
Dolasetron—Flatulence—Epirubicin—uterine cancer	0.000305	0.000957	CcSEcCtD
Dolasetron—Dysgeusia—Epirubicin—uterine cancer	0.000303	0.000951	CcSEcCtD
Dolasetron—Dizziness—Etoposide—uterine cancer	0.000298	0.000935	CcSEcCtD
Dolasetron—Chills—Doxorubicin—uterine cancer	0.000295	0.000926	CcSEcCtD
Dolasetron—Arrhythmia—Doxorubicin—uterine cancer	0.000294	0.000922	CcSEcCtD
Dolasetron—Ill-defined disorder—Epirubicin—uterine cancer	0.000287	0.000901	CcSEcCtD
Dolasetron—Anaemia—Epirubicin—uterine cancer	0.000286	0.000898	CcSEcCtD
Dolasetron—Agitation—Epirubicin—uterine cancer	0.000285	0.000893	CcSEcCtD
Dolasetron—Rash—Etoposide—uterine cancer	0.000284	0.000892	CcSEcCtD
Dolasetron—Dermatitis—Etoposide—uterine cancer	0.000284	0.000891	CcSEcCtD
Dolasetron—Headache—Etoposide—uterine cancer	0.000283	0.000886	CcSEcCtD
Dolasetron—Flatulence—Doxorubicin—uterine cancer	0.000282	0.000886	CcSEcCtD
Dolasetron—Dysgeusia—Doxorubicin—uterine cancer	0.000281	0.00088	CcSEcCtD
Dolasetron—Malaise—Epirubicin—uterine cancer	0.000279	0.000876	CcSEcCtD
Dolasetron—Vertigo—Epirubicin—uterine cancer	0.000278	0.000873	CcSEcCtD
Dolasetron—Syncope—Epirubicin—uterine cancer	0.000278	0.000871	CcSEcCtD
Dolasetron—Palpitations—Epirubicin—uterine cancer	0.000274	0.000858	CcSEcCtD
Dolasetron—Loss of consciousness—Epirubicin—uterine cancer	0.000272	0.000854	CcSEcCtD
Dolasetron—Cough—Epirubicin—uterine cancer	0.00027	0.000848	CcSEcCtD
Dolasetron—Convulsion—Epirubicin—uterine cancer	0.000268	0.000842	CcSEcCtD
Dolasetron—Hypertension—Epirubicin—uterine cancer	0.000267	0.000839	CcSEcCtD
Dolasetron—Ill-defined disorder—Doxorubicin—uterine cancer	0.000266	0.000834	CcSEcCtD
Dolasetron—Anaemia—Doxorubicin—uterine cancer	0.000265	0.000831	CcSEcCtD
Dolasetron—Arthralgia—Epirubicin—uterine cancer	0.000264	0.000827	CcSEcCtD
Dolasetron—Chest pain—Epirubicin—uterine cancer	0.000264	0.000827	CcSEcCtD
Dolasetron—Myalgia—Epirubicin—uterine cancer	0.000264	0.000827	CcSEcCtD
Dolasetron—Agitation—Doxorubicin—uterine cancer	0.000263	0.000826	CcSEcCtD
Dolasetron—Anxiety—Epirubicin—uterine cancer	0.000263	0.000824	CcSEcCtD
Dolasetron—Discomfort—Epirubicin—uterine cancer	0.000261	0.000817	CcSEcCtD
Dolasetron—Malaise—Doxorubicin—uterine cancer	0.000259	0.000811	CcSEcCtD
Dolasetron—Dry mouth—Epirubicin—uterine cancer	0.000258	0.000809	CcSEcCtD
Dolasetron—Vertigo—Doxorubicin—uterine cancer	0.000258	0.000808	CcSEcCtD
Dolasetron—Syncope—Doxorubicin—uterine cancer	0.000257	0.000806	CcSEcCtD
Dolasetron—Confusional state—Epirubicin—uterine cancer	0.000255	0.000799	CcSEcCtD
Dolasetron—Palpitations—Doxorubicin—uterine cancer	0.000253	0.000794	CcSEcCtD
Dolasetron—Anaphylactic shock—Epirubicin—uterine cancer	0.000253	0.000793	CcSEcCtD
Dolasetron—Oedema—Epirubicin—uterine cancer	0.000253	0.000793	CcSEcCtD
Dolasetron—Loss of consciousness—Doxorubicin—uterine cancer	0.000252	0.00079	CcSEcCtD
Dolasetron—Cough—Doxorubicin—uterine cancer	0.00025	0.000784	CcSEcCtD
Dolasetron—Shock—Epirubicin—uterine cancer	0.000249	0.00078	CcSEcCtD
Dolasetron—Convulsion—Doxorubicin—uterine cancer	0.000248	0.000779	CcSEcCtD
Dolasetron—Thrombocytopenia—Epirubicin—uterine cancer	0.000248	0.000776	CcSEcCtD
Dolasetron—Hypertension—Doxorubicin—uterine cancer	0.000247	0.000776	CcSEcCtD
Dolasetron—Tachycardia—Epirubicin—uterine cancer	0.000247	0.000774	CcSEcCtD
Dolasetron—Hyperhidrosis—Epirubicin—uterine cancer	0.000244	0.000766	CcSEcCtD
Dolasetron—Arthralgia—Doxorubicin—uterine cancer	0.000244	0.000765	CcSEcCtD
Dolasetron—Chest pain—Doxorubicin—uterine cancer	0.000244	0.000765	CcSEcCtD
Dolasetron—Myalgia—Doxorubicin—uterine cancer	0.000244	0.000765	CcSEcCtD
Dolasetron—Anxiety—Doxorubicin—uterine cancer	0.000243	0.000763	CcSEcCtD
Dolasetron—Discomfort—Doxorubicin—uterine cancer	0.000241	0.000756	CcSEcCtD
Dolasetron—Anorexia—Epirubicin—uterine cancer	0.000241	0.000756	CcSEcCtD
Dolasetron—Dry mouth—Doxorubicin—uterine cancer	0.000239	0.000748	CcSEcCtD
Dolasetron—Hypotension—Epirubicin—uterine cancer	0.000236	0.000741	CcSEcCtD
Dolasetron—Confusional state—Doxorubicin—uterine cancer	0.000236	0.00074	CcSEcCtD
Dolasetron—Oedema—Doxorubicin—uterine cancer	0.000234	0.000734	CcSEcCtD
Dolasetron—Anaphylactic shock—Doxorubicin—uterine cancer	0.000234	0.000734	CcSEcCtD
Dolasetron—Musculoskeletal discomfort—Epirubicin—uterine cancer	0.00023	0.000722	CcSEcCtD
Dolasetron—Shock—Doxorubicin—uterine cancer	0.00023	0.000722	CcSEcCtD
Dolasetron—Thrombocytopenia—Doxorubicin—uterine cancer	0.000229	0.000718	CcSEcCtD
Dolasetron—Tachycardia—Doxorubicin—uterine cancer	0.000228	0.000716	CcSEcCtD
Dolasetron—Paraesthesia—Epirubicin—uterine cancer	0.000227	0.000712	CcSEcCtD
Dolasetron—Hyperhidrosis—Doxorubicin—uterine cancer	0.000226	0.000709	CcSEcCtD
Dolasetron—Dyspnoea—Epirubicin—uterine cancer	0.000225	0.000707	CcSEcCtD
Dolasetron—Somnolence—Epirubicin—uterine cancer	0.000225	0.000705	CcSEcCtD
Dolasetron—Anorexia—Doxorubicin—uterine cancer	0.000223	0.000699	CcSEcCtD
Dolasetron—Dyspepsia—Epirubicin—uterine cancer	0.000223	0.000698	CcSEcCtD
Dolasetron—Decreased appetite—Epirubicin—uterine cancer	0.00022	0.000689	CcSEcCtD
Dolasetron—Hypotension—Doxorubicin—uterine cancer	0.000219	0.000685	CcSEcCtD
Dolasetron—Fatigue—Epirubicin—uterine cancer	0.000218	0.000683	CcSEcCtD
Dolasetron—Constipation—Epirubicin—uterine cancer	0.000216	0.000678	CcSEcCtD
Dolasetron—Pain—Epirubicin—uterine cancer	0.000216	0.000678	CcSEcCtD
Dolasetron—Musculoskeletal discomfort—Doxorubicin—uterine cancer	0.000213	0.000668	CcSEcCtD
Dolasetron—Paraesthesia—Doxorubicin—uterine cancer	0.00021	0.000659	CcSEcCtD
Dolasetron—Dyspnoea—Doxorubicin—uterine cancer	0.000209	0.000654	CcSEcCtD
Dolasetron—Feeling abnormal—Epirubicin—uterine cancer	0.000208	0.000653	CcSEcCtD
Dolasetron—Somnolence—Doxorubicin—uterine cancer	0.000208	0.000652	CcSEcCtD
Dolasetron—Gastrointestinal pain—Epirubicin—uterine cancer	0.000207	0.000648	CcSEcCtD
Dolasetron—Dyspepsia—Doxorubicin—uterine cancer	0.000206	0.000646	CcSEcCtD
Dolasetron—Decreased appetite—Doxorubicin—uterine cancer	0.000203	0.000638	CcSEcCtD
Dolasetron—Fatigue—Doxorubicin—uterine cancer	0.000202	0.000632	CcSEcCtD
Dolasetron—Urticaria—Epirubicin—uterine cancer	0.000201	0.00063	CcSEcCtD
Dolasetron—Pain—Doxorubicin—uterine cancer	0.0002	0.000627	CcSEcCtD
Dolasetron—Constipation—Doxorubicin—uterine cancer	0.0002	0.000627	CcSEcCtD
Dolasetron—Body temperature increased—Epirubicin—uterine cancer	0.0002	0.000627	CcSEcCtD
Dolasetron—Abdominal pain—Epirubicin—uterine cancer	0.0002	0.000627	CcSEcCtD
Dolasetron—Feeling abnormal—Doxorubicin—uterine cancer	0.000193	0.000604	CcSEcCtD
Dolasetron—Gastrointestinal pain—Doxorubicin—uterine cancer	0.000191	0.0006	CcSEcCtD
Dolasetron—Hypersensitivity—Epirubicin—uterine cancer	0.000186	0.000584	CcSEcCtD
Dolasetron—Urticaria—Doxorubicin—uterine cancer	0.000186	0.000583	CcSEcCtD
Dolasetron—Abdominal pain—Doxorubicin—uterine cancer	0.000185	0.00058	CcSEcCtD
Dolasetron—Body temperature increased—Doxorubicin—uterine cancer	0.000185	0.00058	CcSEcCtD
Dolasetron—Asthenia—Epirubicin—uterine cancer	0.000181	0.000569	CcSEcCtD
Dolasetron—Pruritus—Epirubicin—uterine cancer	0.000179	0.000561	CcSEcCtD
Dolasetron—Diarrhoea—Epirubicin—uterine cancer	0.000173	0.000542	CcSEcCtD
Dolasetron—Hypersensitivity—Doxorubicin—uterine cancer	0.000172	0.00054	CcSEcCtD
Dolasetron—Asthenia—Doxorubicin—uterine cancer	0.000168	0.000526	CcSEcCtD
Dolasetron—Dizziness—Epirubicin—uterine cancer	0.000167	0.000524	CcSEcCtD
Dolasetron—Pruritus—Doxorubicin—uterine cancer	0.000166	0.000519	CcSEcCtD
Dolasetron—Diarrhoea—Doxorubicin—uterine cancer	0.00016	0.000502	CcSEcCtD
Dolasetron—Rash—Epirubicin—uterine cancer	0.000159	0.0005	CcSEcCtD
Dolasetron—Dermatitis—Epirubicin—uterine cancer	0.000159	0.000499	CcSEcCtD
Dolasetron—Headache—Epirubicin—uterine cancer	0.000158	0.000497	CcSEcCtD
Dolasetron—Dizziness—Doxorubicin—uterine cancer	0.000155	0.000485	CcSEcCtD
Dolasetron—Rash—Doxorubicin—uterine cancer	0.000148	0.000463	CcSEcCtD
Dolasetron—Dermatitis—Doxorubicin—uterine cancer	0.000147	0.000462	CcSEcCtD
Dolasetron—Headache—Doxorubicin—uterine cancer	0.000147	0.00046	CcSEcCtD
